Protagonist Therapeutics Inc
XBER:PGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Protagonist Therapeutics Inc
XBER:PGF
|
US |
|
E
|
Eastman Chemical Co
SWB:EAC
|
US |
|
O
|
Okinawa Cellular Telephone Co
XMUN:OCU
|
JP |
|
Innodata Inc
NASDAQ:INOD
|
US |
|
K
|
Kuehne und Nagel International AG
XMUN:KNIA
|
CH |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
S
|
SoftBank Corp
F:3AG1
|
JP |
|
T
|
Toronto-Dominion Bank
XBER:TDB
|
CA |
|
H
|
Hochtief AG
XMUN:HOT
|
DE |
|
Elicio Therapeutics Inc
F:9HA
|
US |
|
S
|
Silvercorp Metals Inc
SWB:S9Y
|
CA |
|
W
|
Wharf Holdings Ltd
F:WHA
|
HK |
|
C
|
Conmed Corp
XBER:EC8
|
US |
|
N
|
Nissan Chemical Corp
SWB:NSC
|
JP |
|
TTM Technologies Inc
F:TT1
|
US |
|
C
|
ConvaTec Group PLC
OTC:CNVVY
|
UK |
|
A
|
Aegean Airlines SA
XBER:32A
|
GR |
|
M
|
MTR Corp Ltd
XMUN:MRI
|
HK |
|
W
|
Williams-Sonoma Inc
LSE:0LXC
|
US |
|
Arhaus Inc
NASDAQ:ARHS
|
US |
|
C
|
CSX Corp
DUS:CXR
|
US |
|
Japan Post Bank Co Ltd
OTC:JPSTF
|
JP |
|
M
|
Mesoblast Ltd
XMUN:LWB
|
AU |
|
T
|
Tompkins Financial Corp
AMEX:TMP
|
US |
Discount Rate
PGF Cost of Equity
Discount Rate
PGF's Cost of Equity, calculated using the formula Risk-Free Rate + Beta x ERP, stands at 9.29%. The Beta, indicating the stock's volatility relative to the market, is 1.16, while the current Risk-Free Rate, based on government bond yields, is 4.44%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.18%.
PGF WACC
Discount Rate
PGF's Weighted Average Cost of Capital (WACC) is calculated as the weighted average of its cost of equity and cost of debt, adjusted for tax. The WACC stands at 9.29%. This includes the cost of equity at 9.29%, calculated as Risk-Free Rate + Beta x ERP, and the cost of debt at 9.06%, reflecting the interest rate on PGF's debt adjusted for tax benefits. The weight of debt in the capital structure is 0%.
What is PGF's discount rate?
PGF's current Cost of Equity is 9.29%, while its WACC stands at 9.29%. The selection of the appropriate discount rate is contingent on the type of cash flows being discounted.
For Equity Valuation: When valuing equity, especially in scenarios where you are discounting cash flows to equity holders (such as Net Income, Earnings Per Share (EPS), or Free Cash Flow to Equity), the Cost of Equity should be used.
For Firm Valuation: In contrast, when valuing the entire firm and discounting cash flows available to both debt and equity holders (like Free Cash Flow to the Firm), the Weighted Average Cost of Capital (WACC) is the appropriate rate.
How is Cost of Equity for PGF calculated?
The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).
This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.
Here is how we calculate the cost of equity for
PGF
How is WACC for PGF calculated?
WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company’s entire operations.
The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure.
Here is how we calculate WACC for
PGF
